|
EP1149095B1
(en)
*
|
1999-01-28 |
2004-01-21 |
Neurosearch A/S |
Novel azabicyclo derivatives and their use
|
|
EP1147112B1
(en)
*
|
1999-01-29 |
2003-10-29 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
|
US7265115B2
(en)
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
NZ513575A
(en)
*
|
1999-05-04 |
2003-07-25 |
Neurosearch As |
Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
|
|
MXPA02005884A
(es)
*
|
1999-12-14 |
2002-10-23 |
Neurosearch As |
Heteroaril-diazabicicloalcanos novedosos.
|
|
MY145722A
(en)
*
|
2000-04-27 |
2012-03-30 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
EP1289996B1
(en)
|
2000-05-25 |
2005-04-06 |
Targacept, Inc. |
Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
|
|
WO2001091925A1
(en)
*
|
2000-05-31 |
2001-12-06 |
Board Of Control Of Michigan Technological University |
Compositions and methods for wood preservation
|
|
ATE287888T1
(de)
*
|
2000-07-04 |
2005-02-15 |
Neurosearch As |
Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung
|
|
US6579878B1
(en)
|
2000-07-07 |
2003-06-17 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6624167B1
(en)
|
2000-08-04 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
EP1358177B1
(en)
*
|
2000-10-13 |
2006-08-02 |
NeuroSearch A/S |
Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
|
|
ATE289310T1
(de)
*
|
2001-06-01 |
2005-03-15 |
Neurosearch As |
Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
|
|
ATE378048T1
(de)
†
|
2002-12-06 |
2007-11-15 |
The Feinstein Inst Medical Res |
Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
|
|
US7238715B2
(en)
|
2002-12-06 |
2007-07-03 |
The Feinstein Institute For Medical Research |
Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
DE602006019561D1
(de)
|
2005-02-16 |
2011-02-24 |
Neurosearch As |
Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren
|
|
US8316104B2
(en)
|
2005-11-15 |
2012-11-20 |
California Institute Of Technology |
Method and apparatus for collaborative system
|
|
CA2632642A1
(en)
|
2005-12-06 |
2007-06-14 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives and their medical use
|
|
EP1984365A1
(en)
|
2006-02-10 |
2008-10-29 |
NeuroSearch A/S |
3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
|
WO2007090887A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Neurosearch A/S |
3, 9-diazabicyclo [3.3. 1]nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
|
|
US7687523B2
(en)
|
2006-02-10 |
2010-03-30 |
Neurosearch A/S |
3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
|
|
WO2007093601A1
(en)
|
2006-02-14 |
2007-08-23 |
Neurosearch A/S |
3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
|
|
TW200845977A
(en)
*
|
2007-03-30 |
2008-12-01 |
Targacept Inc |
Sub-type selective azabicycloalkane derivatives
|
|
EP1977746B8
(en)
|
2007-04-02 |
2014-09-24 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
|
US8697722B2
(en)
|
2007-11-02 |
2014-04-15 |
Sri International |
Nicotinic acetylcholine receptor modulators
|
|
WO2009058120A1
(en)
*
|
2007-11-02 |
2009-05-07 |
Sri International |
Nicotinic acetylcholine receptor modulators
|
|
US20110142758A1
(en)
*
|
2008-06-10 |
2011-06-16 |
Neurosearch A/S |
Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
|
|
JP5421368B2
(ja)
|
2008-08-01 |
2014-02-19 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
テトラヒドロピリジニルおよびジヒドロピロリル化合物およびそれらの使用
|
|
WO2011085389A1
(en)
|
2010-01-11 |
2011-07-14 |
Astraea Therapeutics, Llc |
Nicotinic acetylcholine receptor modulators
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
薬剤送達方法及びシステム
|
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
AU2019279884B2
(en)
|
2018-05-29 |
2025-01-30 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
JP2022507660A
(ja)
|
2018-11-16 |
2022-01-18 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
温度によって調節される経皮薬剤送達システム
|